Bronchiectasis clinical trials

Explore recruiting bronchiectasis clinical trials.

Recruiting bronchiectasis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bronchiectasis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Double-blinded, Placebo-controlled, Parallel Group, Phase 2a Study to Assess the Activity, Safety, and Tolerability of SAR445399 in Adult Participants with Non-Cystic Fibrosis Bronchiectasis (NCFB).

Poland, Spain, France, Netherlands, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2 randomized, double-blind, placebo-controlled study to investigate efficacy, safety, immunogenicity, and pharmacokinetics, of GSK3862995B in participants with bronchiectasis

Denmark, France, Spain, Italy, Germany, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Macroleave: Impact of discontinuation of long-term macrolides in stable Non Cystic Fibrosis Bronchiectasis : a multicenter randomized controlled trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomised, double-blind, parallel group, roll-over study evaluating long-term safety and efficacy of oral doses of BI 1291583 q.d. in patients with bronchiectasis (ClairleafTM)

Netherlands, Hungary, Portugal, Czechia, Italy, France +8 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Benefits of inhalation of 7% hypertonic saline solution prior to ELTGOL physiotherapy, in patients with bronchiectasis. A randomized controlled trial.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

PHARMACOLOGICAL STRATEGIES OF INHALED ANTIBIOTHERAPY IN BRONCHIECTASIS WITH CHRONIC BRONCHIAL INFECTION: BRONCHIPHARMA STUDY.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Bronchiectasis trials by city

Bronchiectasis in Toronto Bronchiectasis in Vancouver Bronchiectasis in Montreal Bronchiectasis in Calgary Bronchiectasis in Edmonton Bronchiectasis in Ottawa Bronchiectasis in Winnipeg Bronchiectasis in Quebec City Bronchiectasis in Hamilton Bronchiectasis in Kitchener Bronchiectasis in London Bronchiectasis in Halifax Bronchiectasis in New York Bronchiectasis in Los Angeles Bronchiectasis in Chicago Bronchiectasis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease